Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs Rani Therapeutics Holdings, Inc. (RANI)

Champions Oncology, Inc. and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Rani Therapeutics Holdings, Inc. are of similar size ($72.0M and $66.3M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against 6.65%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −597.0%) and the lower return on invested capital (−626.2% vs 0.00%). Across the 16 metrics below, Champions Oncology, Inc. leads on 10 and Rani Therapeutics Holdings, Inc. on 6.

Valuation

Metric CSBR RANI Biotechnology median
P/E n/m n/m 10.60
P/S 1.10 20.02 9.40
P/B 14.96 2.11 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 200.80 n/m 0.66
EV/Sales 1.03 12.57 9.02
Earnings yield (1.67%) (50.00%) (32.88%)
Free cash flow yield (9.16%) (20.12%) (23.13%)

Profitability

Metric CSBR RANI Biotechnology median
Gross margin 49.82% 100.00% 68.51%
Operating margin (1.68%) (652.78%) 0.00%
Net margin (1.87%) (596.97%) 0.00%
Free cash flow margin (10.08%) (402.83%) 0.00%
Return on equity (28.38%) (155.24%) (51.96%)
Return on assets (3.56%) (77.54%) (46.06%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR RANI Biotechnology median
Revenue growth (TTM) 6.65% 78.73% 6.76%
EPS growth (last fiscal year) (124.24%) 57.14% 29.88%
Revenue growth, 5-year CAGR 7.68% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSBR RANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 5.31 4.97
Net debt to EBITDA (20.56) 1.33 1.01

Dividend

Metric CSBR RANI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CSBR RANI Biotechnology median
Market cap 66.26m 71.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack